Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Prudential PLC Regulatory Filings 2018

Jul 2, 2018

4668_rns_2018-07-02_77ce41ca-ae6a-4a1a-8c3a-784551a6b5bb.html

Regulatory Filings

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 2961T

Prudential PLC

02 July 2018

Prudential plc ("Prudential")

TOTAL VOTING RIGHTS AND ISSUED SHARE CAPITAL

In accordance with the provisions of the Disclosure Guidance and Transparency Rules issued by the Financial Conduct Authority, Prudential notifies the market of the following:

As at 30 June 2018, Prudential's issued share capital admitted to trading consisted of 2,591,872,867 ordinary shares of 5p each. Each ordinary share carries the right to one vote in all circumstances at general meetings of Prudential. Prudential does not hold any Treasury Shares.

The total number of voting rights in Prudential is therefore 2,591,872,867 and this figure may be used by shareholders (and others with notification obligations) as the denominator for the calculations by which they will determine whether they are required to notify their interest in, or a change to their interest in, Prudential under the Disclosure Guidance and Transparency Rules.

ADDITIONAL INFORMATION:

Prudential plc is not affiliated in any manner with Prudential Financial, Inc, a company whose principal place of business is in the United States of America.

Contact

Chris Smith, Deputy Group Secretary, +44 (0)20 7548 2115

Hamza Aynashe,  Company Secretarial Assistant, +44 (0)20 7548 3225

Date of notification

2 July 2018

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

TVRSSSFDEFASELW